May Inflation Stays Mild, Boosts Rate Cut Hopes

Core PCE rises to 2.7% as spending and income decline U.S. inflation remained subdued in May, with the personal...

Nike Stock Jumps as Sales Improve and Tariffs Hit

Sneaker giant forecasts mid-single digit sales drop, cuts China reliance Nike shares soared 15.2% on Friday after the company...

May Inflation Stays Mild, Boosts Rate Cut Hopes

Core PCE rises to 2.7% as spending and income decline U.S. inflation remained subdued in May, with the personal consumption expenditures (PCE) price index—the Federal Reserve’s preferred gauge—rising just 0.1%...

Nike Stock Jumps as Sales Improve and Tariffs Hit

Sneaker giant forecasts mid-single digit sales drop, cuts China reliance Nike shares soared 15.2% on Friday after the company projected that profit and revenue declines will moderate in the current...

AstraZeneca Eyes $80 Billion Goal with New Cancer Drugs

AstraZeneca (AZN) is aiming to meet its ambitious $80 billion target by 2030, with three promising cancer treatments...

New Covid Variant NB.1.8.1 Spreads Globally, Concerns Rise

A new COVID variant, NB.1.8.1, is gaining traction globally, including in the United States. The World Health Organization...

Google’s New Gemini AI Feature Summarizes Videos in Drive

Google is expanding its Gemini AI feature to provide greater insight into the videos stored in Google Drive....

Australia’s Inflation Rises Slightly Amid Tariff Turmoil

Australia’s inflation rate edged higher in April, surpassing economists' expectations and coming at a time of heightened market...

US Consumer Confidence Rises After Tariff Easing with China

Americans have upgraded their outlook on the economy for...

Russia Attacks Ukraine for Third Consecutive Night

Russia launched a third consecutive night of attacks on...

Health

Nestlé to Eliminate Synthetic Food Colors by Mid-2026

U.S. food industry accelerates shift to cleaner labels amid new health regulations Nestlé USA announced Wednesday that it will eliminate all synthetic food colors from...

FDA Launches Fast-Track Reviews for Key Medicines

New initiative cuts drug review time to as little as 30 days The U.S. Food and Drug Administration (FDA) announced Tuesday a new fast-track initiative...

BioNTech Acquires CureVac for $1.25 Billion in Share Deal

Deal Overview German biotech firm BioNTech has announced the acquisition of its rival CureVac for approximately $1.25 billion in BioNTech shares. This move aims to...

General News

Nike Stock Jumps as Sales Improve and Tariffs Hit

Sneaker giant forecasts mid-single digit sales drop, cuts China...

Elon Musk Fires Tesla VP Amid Sales Declines and Political Backlash

Omead Afshar dismissed as pressure mounts on Tesla's operations...

Nestlé to Eliminate Synthetic Food Colors by Mid-2026

U.S. food industry accelerates shift to cleaner labels amid...

Fed Proposes Major Rollback of Bank Capital Rules

New eSLR change aims to boost Treasury market but...

Latest Articles

Electric Bills Climb Faster Than Inflation in the U.S.

Data centers, outdated grids, and rising demand push prices up Electricity prices are outpacing overall inflation in the U.S., with households paying 4.5% more for...

Amazon Expands Fast Delivery to 4,000 Rural U.S. Areas

$4B expansion targets underserved towns ahead of Prime Day Amazon announced Tuesday that it will bring same- and next-day delivery services to more than 4,000...

Stocks Rally as Iran’s Response Calms Oil Market

Dow jumps nearly 375 points while oil tumbles 7% U.S. stocks climbed Monday as investors welcomed Iran’s restrained response to American airstrikes over the weekend....

Oman to Introduce Gulf’s First Personal Income Tax

5% tax on high earners aims to boost fiscal diversification Oman has issued a royal decree to become the first Gulf nation to implement a...

Markets Slip Amid Geopolitical Tensions and Fed Uncertainty

S&P 500 logs third straight loss as rate cut timeline and Middle East risks weigh on sentiment The S&P 500 slipped 0.22% on Friday to...

Accenture Drops 7% Despite Revenue Beat and Raised Outlook

Investors focus on falling bookings and growth concerns Shares of Accenture (NYSE: ACN) slid 6.8% to close at $285.49 on Thursday after the company reported...

Subscribe